| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.379 | 11.785 | 9.776 | 12.575 | 11.081 | 9.413 | 9.400 | 11.291 | 13.002 | 11.364 |
| Total Income - EUR | 14.379 | 11.785 | 9.776 | 13.212 | 11.574 | 9.413 | 9.711 | 12.006 | 13.731 | 11.554 |
| Total Expenses - EUR | 11.852 | 10.770 | 10.741 | 11.833 | 8.029 | 8.255 | 8.928 | 7.748 | 7.061 | 5.323 |
| Gross Profit/Loss - EUR | 2.527 | 1.014 | -964 | 1.379 | 3.545 | 1.158 | 784 | 4.257 | 6.670 | 6.231 |
| Net Profit/Loss - EUR | 2.095 | 661 | -1.258 | 983 | 3.198 | 897 | 544 | 3.979 | 5.521 | 5.215 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Empop-Riflame S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.160 | 6.853 | 2.616 | 767 | 9.863 | 6.377 | 3.764 | 1.257 | 0 | 0 |
| Current Assets | 3.171 | 1.104 | 2.661 | 1.581 | 1.224 | 1.922 | 201 | 4.166 | 6.929 | 6.128 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.953 | 981 | 25 | 168 | 48 | 0 | 10 | 12 | 2.481 | 953 |
| Cash | 1.218 | 122 | 2.635 | 1.413 | 1.175 | 1.922 | 191 | 4.154 | 4.449 | 5.175 |
| Shareholders Funds | 8.472 | 5.681 | 3.728 | 1.077 | 4.215 | 5.034 | 2.657 | 4.076 | 5.621 | 5.312 |
| Social Capital | 45 | 45 | 44 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 5.859 | 2.276 | 1.548 | 1.271 | 6.872 | 3.265 | 1.308 | 1.347 | 1.308 | 816 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Empop-Riflame S.r.l.